Artivion, Inc.
NYSE:AORTMedical - Devices
-$0.11 today
- Market cap
- $904.56M
- Beta
- 1.26
- P/E (TTM)
- 86.7
- EPS (TTM)
- $0.24
Volume 0.91M
Average 0.64M
AORT Long-term Debt
Borrowings due after more than one year.
Artivion, Inc.NYSE: AORT
Long-term Debt · Q1 FY2026 · quarter ended Mar 2026
Long-term debt falls 31.5% from a year ago
Long-term debt stood at $215.35M at the end of Q1 FY2026, down 31.5% from a year earlier and down 13.7% from the prior quarter. Over 3 fiscal years it compounded at -6.6% a year.
Context
- Long-term debt amounted to 24.4% of total assets at the end of Q1 FY2026, down 15.4 pp from a year earlier.
- Long-term debt increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether long-term debt keeps falling in the next quarterly balance sheet after a -31.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 249.54M USD
- Year-over-year change
- -20.6%
- 4-year CAGR
- -5.1%
| Period | Period end | Long-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 249.54M | -20.6% |
| FY2024 | 2024-12-31 | 314.15M | +2.8% |
| FY2023 | 2023-12-31 | 305.53M | -0.3% |
| FY2022 | 2022-12-31 | 306.5M | -0.3% |
| FY2021 | 2021-12-31 | 307.49M | — |
Long-term Debt vs competitors
How AORT compares with its peers on the latest reported figures
- AORT's Mar 2026 long-term debt of $215.35M is the 5th highest of the 11 companies compared; the peer median is $138.16M.
- Its year-over-year change of -31.5% is the 6th highest of 9, against a peer median of -10.0%.
- Long-term debt amounts to 24.4% of total assets for AORT, versus a peer median of 14.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jul 2026 | $1.24B | +2.9% | +11.8% | 36.2% | |
| Sep 2026 | $1.1B | -73.6% | +12.2% | 18.5% | |
ARDTArdent Health Partners, LLC | Mar 2026 | $1.07B | -1.6% | -2.2% | 20.4% |
| Jun 2026 | $223.46M | +408.4% | — | 26.8% | |
| Mar 2026 | $215.35M | -31.5% | -6.6% | 24.4% | |
| Jun 2026 | $154.16M | -43.5% | -12.9% | 7.1% | |
| Jun 2026 | $122.15M | -18.3% | +88.4% | 23.4% | |
| Jun 2026 | $61.6M | -63.6% | +6.3% | 4.2% | |
| Mar 2026 | $51.66M | +0.3% | +0.3% | 10.6% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AORT) | $138.16M | -10.0% | +6.3% | 14.6% | |
Competitors are the stored peer set for AORT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 55.01M | 39.35M | 58.94M | 53.46M | 64.91M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 58.11M | 69.58M | 74.14M | 85.89M | 103.68M |
| Inventory | 76.97M | 74.48M | 81.98M | 79.77M | 92.43M |
| Other Current Assets | 42.86M | 46.37M | 49.8M | 70.96M | 42.54M |
| Total Current Assets | 247.7M | 247.33M | 280.67M | 290.08M | 303.55M |
| Property, Plant & Equipment (Net) | 83.24M | 80.53M | 82.18M | 76.13M | 99.69M |
| Goodwill | 250M | 243.63M | 247.34M | 240.96M | 254.09M |
| Intangible Assets | 201.5M | 182.65M | 172.23M | 156.38M | 156.5M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 2.36M | 1.31M | 1.09M | 1.07M | 1.2M |
| Other Non-current Assets | 8.27M | 7.34M | 8.89M | 24.48M | 69.77M |
| Total Non-current Assets | 545.36M | 515.46M | 511.73M | 499.02M | 581.25M |
| Total Assets | 793.05M | 762.8M | 792.4M | 789.1M | 884.8M |
| Account Payables | 10.4M | 12M | 13.32M | 17.97M | 16.04M |
| Short-term Debt | 1.63M | 1.61M | 1.45M | 195K | 5.38M |
| Tax Payables | 3.63M | 2.64M | 3.84M | 2.93M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 700K | 1.31M | 21.11M | 583K | 50.17M |
| Total Current Liabilities | 44.95M | 49.68M | 57.86M | 66.82M | 101.56M |
| Long-term Debt | 307.49M | 306.5M | 305.53M | 314.15M | 249.54M |
| Deferred Tax Liabilities | 28.8M | 24.5M | 21.85M | 20.18M | 24.31M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 61.84M | 52.9M | 77.99M | 68.92M | 24.03M |
| Total Non-current Liabilities | 447.37M | 428.79M | 452.76M | 446.08M | 335.01M |
| Total Liabilities | 492.32M | 478.47M | 510.62M | 512.9M | 436.56M |
| Common Stock | 414K | 418K | 426K | 434K | 493K |
| Retained Earnings | 1.98M | (17.22M) | (47.91M) | (61.27M) | (51.5M) |
| Accumulated OCI | (9.89M) | (21.61M) | (12.01M) | (24.93M) | (2.72M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 300.73M | 284.33M | 281.78M | 276.2M | 448.23M |
| Total Debt | 362.04M | 356.83M | 358.34M | 362.26M | 292.04M |
| Net Debt | 307.03M | 317.48M | 299.4M | 308.8M | 227.13M |
Artivion, Inc.
NYSE:AORT
Intrinsic Alpha fair value
Locked
Current Price
$18.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.